ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 59 filers reported holding ADICET BIO INC in Q3 2021. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $2,133,000 | -2.6% | 150,000 | 0.0% | 0.78% | -10.7% |
| Q2 2022 | $2,190,000 | -29.2% | 150,000 | -3.2% | 0.88% | -15.4% |
| Q1 2022 | $3,095,000 | -32.7% | 155,000 | -41.1% | 1.04% | -18.3% |
| Q4 2021 | $4,600,000 | +312.2% | 263,000 | +84.8% | 1.27% | +332.8% |
| Q3 2021 | $1,116,000 | -23.8% | 142,289 | 0.0% | 0.29% | -13.8% |
| Q2 2021 | $1,464,000 | -21.3% | 142,289 | 0.0% | 0.34% | -34.2% |
| Q1 2021 | $1,861,000 | – | 142,289 | – | 0.52% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 2,115,385 | $30,017,000 | 10.26% |
| Foresite Capital Management V, LLC | 680,000 | $9,670,000 | 7.44% |
| Foresite Capital Opportunity Management V, LLC | 170,000 | $2,417,000 | 7.26% |
| DAFNA Capital Management LLC | 935,766 | $13,307,000 | 3.58% |
| COWEN AND COMPANY, LLC | 2,443,246 | $34,743,000 | 3.32% |
| JOHNSON & JOHNSON | 728,944 | $10,366,000 | 3.05% |
| Decheng Capital Management III (Cayman), LLC | 580,000 | $8,248,000 | 2.99% |
| Ally Bridge Group (NY) LLC | 244,400 | $3,475,000 | 2.29% |
| Orbimed Advisors | 7,447,140 | $105,898,000 | 1.97% |
| Cormorant Asset Management, LP | 1,400,000 | $19,908,000 | 1.39% |